Nothing for Eisai to question, they had all of the study information on the drug in addition to the safety record and real world results. Belviq failure or lack of great success is not the fault of the drug or Arena. It is the fault of Eisai and their inability to market this amazing new and novel drug. Seriously they had the first new compound approved for weight loss in 14 years and they totally dropped the ball because of their lack of experience bringing a new product to market and building brand name recognition.
The fault lies right on their shoulders and they have compounded that failure by being greedy and stupid failing to recognize their shortcomings and bringing on a marketing partner as they did with Aricept... They had the opportunity to sell off the drug but got to greedy and chased off the prospect..
I fault Arena management for failing to hold their partner to any kind of standard and refusing to get involved in the marketing of the drug.
We had a pull back retested the 4.50 level and closed over 4.50. Under normal circumstances ttaders would be watching for a break out and a new trend higher. Lets see if this can stick, bot so sure with all the games that are played here.
So what you are saying is those buying today will be doing better rhen those buying the potential before Locaserin was approved and the pipeline was developed. You are basically saying, buy all you can, you are getting a better deal the the original sharhilders.
Thank you for that insight.
Only way for that ti happen is for Eisai to voluntarily go away. And they had the chance and got greedy.
It would require a marketing company that had creativity and the ability to change and be nimble. A marketing company to adapt and evolve with the market. One commercial run at off time that is not well done is not going to build brand recognition or a brand for that matter. You need a spokesperson, you need to be seen everywhere all the time in front of the eyes of consumers. The doctor education route produced very little results when you consider over 70,000 have written at least one sxript. We should be at 70k a month if all of them had one patient on it. They are not continuing to use Belviq in their oractices even with the price reduction and all of the peer papers that say Belviq and weight loss medication should be considered in a lifestyle modification program.
That is b3cause Eisai has no real experience building a brand name and brand awareness. Their sales staff were clearly not very good. If was Pfizer that built Aricept into a multi billion dollar drug. Eisai screwed that one up to and had to bring them on.
Eisai had the chance to do it with just recently and they got greedy and stupid. Now we are at the mercy of 2 idiotic management teams.
Investors need to make a lot of noise at the company and on Belviq social media. Not here, do it where it will be noticed and something will be done about it.
Now we get articles talking about the obvios tv ad slow down. Where were they the last 90 days. What I want to know is what the heII is Arena going to do about it.
Nothing but HOD after HOD, we should consider you a contra indicator. Blew out the 4.50 resistance and never looked back on 200% above average daily volume.
The point is the article was removed.
They should have pulled out of Greece long ago. No way the politicians there will do the right then. Bug reser coming, many on government dole and unreasonable pensions about to lose the monthly income for life.